DrugAlert provides timely advice direct to your inbox and is based on information from drug manufacturers regarding critical changes to medication access such as the discontinuation, short supply or unavailability, recalls and other important drug-related information. See below to view the most recent volumes of DrugAlert.
HPS Pharmacies wishes to advise that Novo Nordisk is discontinuing the following insulin products: Mixtard® 30/70 InnoLet®, 3mL Insulin neutral human 30 units/mL + Insulin isophane human 70 units/mL ARTG 169628 Mixtard® 30/70 Penfill®,…
Read more
HPS Pharmacies wish to advise that Pfizer is experiencing a supply interruption for Heparinised Saline as follows: Heparinised Saline Heparin sodium 50 IU/5mL ARTG 66684 This supply interruption is expected to resolve by the…
Read more
HPS Pharmacies wish to advise that Pfizer is experiencing a supply interruption for heparin as follows: Heparin Sodium Heparin sodium 5000IU/5mL ARTG 49232 This supply interruption is expected to be resolved by end of…
Read more
Further to DrugAlert vol 954, HPS Pharmacies wishes to advise that Mundipharma has decided to reinstate the following eye drops: Timoptol® Eye Drops Timolol maleate 0.5% ARTG 28775 Timoptol®-XE Eye Drops Timolol maleate 0.5%…
Read more
HPS Pharmacies wish to give notice that Seqirus, in consultation with the Therapeutic Goods Administration (TGA), has initiated a drug recall for Palexia® SR as follows: Palexia® SR 50mg Tablets Tapentadol (as hydrochloride) 50…
Read more
HPS Pharmacies wish to give notice that Medsurge, in consultation with the Therapeutic Goods Administration (TGA), has initiated a drug recall for folic acid injectables as follows: Folic Acid Ampoules Folic acid 5mg/1mL Products…
Read more
